Intravenous Administration for Rapid Control Intravenous (IV) ketorolac is utilized in scenarios requiring immediate pain control or when a rapid titration of dosage is necessary. Since the drug and its metabolites are excreted by the kidneys, reduced clearance in patients with renal dysfunction can lead to accumulation and increased toxicity.
Ketorolac IM Versus IV Administration: Comparing Efficacy and Safety
Similarly, intranasal administration offers a middle ground, providing faster absorption than oral tablets but generally resulting in lower peak concentrations than the IM or IV routes. Oral and Nasal Routes: Convenience and Limitations Oral ketorolac is generally reserved for the later stages of pain management, specifically for transition from injectable therapy.
Similarly, liver disease can impede the metabolic conversion of the prodrug, altering the efficacy and safety profile, which underscores the importance of patient-specific assessment before administration. However, the IV route necessitates careful monitoring due to the potential for a more pronounced systemic effect compared to IM injection.
Ketorolac IM Versus IV: Comparing Efficacy and Safety
Intramuscular Injection: The Standard for Acute Settings Intramuscular (IM) injection is the most common and traditional route for administering ketorolac in acute care environments. The total daily dose is strictly capped at 120 mg for adults, with treatment durations limited to a maximum of five days.
More About Ketorolac route of administration
Looking at Ketorolac route of administration from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Ketorolac route of administration can make the topic easier to follow by connecting earlier points with a few simple takeaways.
